Tech Company Financing Transactions

NeuroVasc Technologies Funding Round

On 5/22/2018, NeuroVasc Technologies raised $6.3 million in Series B financing from Shangbay Capital and private investors.

Transaction Overview

Announced On
5/22/2018
Transaction Type
Venture Equity
Amount
$6,300,000
Round
Series B
Investors

Shangbay Capital (Lead Investor) (William Dai)

Proceeds Purpose
We have been seeing good early clinical results, and we plan to expand on this clinical work with the current financing.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
23141 Verdugo Dr. 105
Laguna Hills, CA 92653
USA
Email Address
Overview
NeuroVasc, Inc. is a privately-held medical device company founded in 2015 focused on developing innovative, state-of-the-art devices for the treatment of neurovascular conditions, such as strokes.
Profile
NeuroVasc Technologies LinkedIn Company Profile
Social Media
NeuroVasc Technologies Company Twitter Account
Company News
NeuroVasc Technologies News
Facebook
NeuroVasc Technologies on Facebook
YouTube
NeuroVasc Technologies on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
James Ma
  James Ma LinkedIn Profile  James Ma Twitter Account  James Ma News  James Ma on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/22/2018: Outreach venture capital transaction
Next: 5/22/2018: Zapata Computing venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary